Advertisement

Topics

Active-Investors: Wired News - Biogen Presented New Interim Phase-2 Results from NURTURE Evaluating Efficacy and Safety of SPINRAZA at MDA Clinical Conference

08:00 EDT 14 Mar 2018 | FinanzNachrichten

Stock Monitor: Concordia Intl. Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 14, 2018 / Active-Investors.com has just released a free research report on Biogen Inc. (NASDAQ: BIIB).If you...

Original Article: Active-Investors: Wired News - Biogen Presented New Interim Phase-2 Results from NURTURE Evaluating Efficacy and Safety of SPINRAZA at MDA Clinical Conference

NEXT ARTICLE

More From BioPortfolio on "Active-Investors: Wired News - Biogen Presented New Interim Phase-2 Results from NURTURE Evaluating Efficacy and Safety of SPINRAZA at MDA Clinical Conference"

Advertisement
Quick Search
Advertisement
Advertisement